The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that aims to improve population health by connecting leaders and decision makers with the best available evidence and experience. It does this work by:
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
May CI Van Schalkwyk
Back to The Milbank Quarterly
We thank Dr. Sim and colleagues for their comments. Industry funding of research and health information campaigns, including through intermediary bodies, is an area of growing research, and we welcome this opportunity for discussion about the issue. In the interest of transparency, we wish to emphasize the ideas and evidence that inform our research, as these considerations can too quickly be overlooked when the debate is narrowed to a particular issue about any given manuscript. As a research group constituted of public health researchers and medical doctors, we are first and foremost dedicated to addressing the harms of alcohol use, a major global health problem that continues to be a leading cause of morbidity and mortality in high‐, middle‐ and low‐income countries.1 We also believe that the provision of health information is a form of public health intervention, and as such it must be based on robust independent evidence, overseen by strong systems of governance not compromised by conflicts of interests, and held to high standards, including being subjected to external independent review.
Our research is also informed by decades of evidence detailing how industries, particularly those which profit from the production, marketing, and sale of harmful products, expend considerable resources carefully monitoring, influencing, and managing what is known about the harms of their products.2 They also seek to counter evidence that threatens their profits and power. This influence is exerted through many diverse channels and employs elaborate strategies.3 It is within this context that we conduct our research, and advocate for the importance of ensuring that any information provided in the interest of promoting public health maintains evidential integrity along the entire path from initial development to final publication. This understanding must lead those who take part in the dissemination of such information to ensure that this path is transparent and open to scrutiny. It also requires that health professionals acknowledge the threat that harmful industry influence poses to health information and take action to protect the integrity of that information, including recognition that these biases, distortions, and misinformation may be subtly and sometimes unconsciously introduced by those involved.
In this context we find it disappointing that, as independent medical advisors, Sim and colleagues do not engage with any of the substantive findings nor with the evidence we cited supporting the need for this study nor with the implications of our findings.<4 Instead, their comments appear to be largely confined to defending the reputation of Drinkaware, with whom they have previously been coauthors.5
Even if Drinkaware is formally independent of the alcohol industry that funds it, its messaging and information materials consistently align closely with the misinformation and framings used by other alcohol industry (AI)‐funded organizations and by alcohol industry companies themselves.6,7 This includes strategically ambiguous messaging, omissions, and mixed messages over alcohol‐related cancers, particularly breast cancer, as shown previously.8-10 Drinkaware’s misinformation on pregnancy‐related alcohol harms is also consistent with misinformation from other AI‐funded organizations, as described previously.11,12
The use of marketing‐style messages from AI Corporate Social Responsibility bodies has also been shown before, and Drinkaware uses similar mixed messages.13 Given Sim et al.’s interest in comparative studies, we refer them to our analysis of the Twitter feeds of Drinkaware and other AI‐funded bodies, in which we compared non‐AI‐funded bodies with AI‐funded bodies, including Drinkware.13 The study found that AI‐funded bodies are significantly less likely to tweet about alcohol harms, about the influence of marketing and advertising, about cancers, and about regulatory measures addressing pricing and advertising restrictions, among others (See Table 1 below, reproduced from the paper). AI‐funded organizations like Drinkaware, were also less likely to tweet about the impact of drinking on emergency services. We note again, however, that in analyzing misinformation, there is no logical need for comparison with other organizations. Analyses of tobacco industry documents, or other misinformation, do not logically require such approaches. Our current analysis is not an epidemiological study, but a documentary analysis. We explain this in detail in our paper.
Table 1. Twenty most common topics tweeted about in 2016 by alcohol industry‐funded and non‐industry‐funded bodies (non‐industry bodies shaded in grey) n (%)
Reproduced from Alcohol Industry CSR Organisations: What Can Their Twitter Activity Tell Us about Their Independence and Their Priorities? A Comparative Analysis” Int. J. Environ. Res. Public Health 2019;16(13):2421.
Why might it be, then, that AI‐funded charities spread misinformation about serious alcohol harms, and are surprisingly coy about certain key topics, including the role of alcohol advertising and marketing? It comes down to conflicts of interest, the importance of which Sim et al. dispute. The alcohol industry is reliant on levels of sales that are consistent with drinking at harmful levels for a significant proportion of its overall revenue.14,15 It therefore has a clear conflict of interest with respect to reducing consumption levels, and there is substantial evidence that such conflicts guide both corporate political activity and corporate social responsibility activities, such as funding charities.16,17
Sim et al. also cite Gray et al.’s comments on conflicts of interest, in support of their argument. They have omitted a key part of the context. Our commentary on Gray et al.’s paper18 pointed out that they had misrepresented their own conflicts of interest, particularly their alcohol industry funding, and had placed the relevant statements in the supplement where readers were unlikely to see them, despite the journal guidelines.18 It is remarkable that Sim et al. seem to agree that alcohol industry funding does not represent an important conflict of interest when writing about alcohol—particularly the harms and how to address these.
We stand by our statement that “in the case of AI misinformation or disinformation we also need to consider the role of clinicians and others involved in advising these organizations, and whether this is consistent with their professional codes of ethics.” This is one of many lessons that public health has learned from the history of the tobacco industry. It is well‐documented that the tobacco industry has been dependent on clinical and other experts to provide cover for their disinformation, as part of “healthwashing” campaigns.19 Other harmful industries, including parts of the food and beverage industries, and the fossil fuel industry, have done the same.2,20 To reduce the risk to public health, it is therefore crucial to consider how industry‐funded structures, and strategic partnerships with legitimate experts, may enable the propagation of misinformation. The evidence of the tobacco and other harmful industries shows us clearly that these structures include industry‐funded consultants and advisors, who may themselves be unaware of the extent of the supporting role they play.19,21
We again encourage Sim et al. to consider where the misinformation and industry‐friendly framings are introduced, despite their involvement as expert advisors.6,8,9,12 They may also wish to consider whether their advice is sufficient, as opposed to independent and transparent scrutiny of Drinkaware’s materials and processes.
In short, repeated analyses have shown that alcohol industry‐funded charities are a vector of industry‐friendly misinformation. These are not “allegations” as Sim et al. call them. These are consistent, replicated peer‐reviewed scientific findings. Sim and colleagues’ comments ignore the fundamental problem of Drinkaware’s misinformation. In the words of a previous analysis, we still need to “Be Aware of Drinkaware.”6
Read on Wiley Online Library
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, political, historical, legal, and ethical dimensions of health and health care policy.